Active Pharmaceutical Ingredients Index A to Z

Browse Alphabetically


Also known as: X4p002

Under Development Product/Pipeline Product

pdf

Also known as: X4p001 rd

Under Development Product/Pipeline Product

pdf

Also known as: X4p001 io

Under Development Product/Pipeline Product

pdf

Also known as: Vrx 621698

XEN1101, A Selective KV7 Potassium Channel Modulator for the Treatment of Epilepsy. XEN1101, a KV7 potassium channel opener, for the treatment of epilepsy. We acquired XEN1101 from 1st Order Pharmaceuticals...

pdf

Also known as: Xen 901

XEN901, A Selective NaV1.6 Sodium Channel Inhibitor for the Treatment of Epilepsy. We are developing XEN901, a potent, highly selective NaV1.6 sodium channel inhibitor, for the treatment of epilepsy,...

pdf

Also known as: Xc-001

XC001 is an investigational gene therapy for the treatment of patients with refractory angina with no treatment options. Patients who have exhausted pharmacologic options and are not eligible for PCI or...

pdf

Also known as: Xc-002

XC002, Discovery stage is the second XyloCor program and it is being developed for regeneration of cardiac tissue in patients who have poorly functioning hearts as a result of past heart attacks and resulting...

pdf

Also known as: Xx

GLPG1205 is a GPR84 inhibitor discovered by Galapagos and fully proprietary to Galapagos. GLPG1205 showed a reduction in signs and symptoms in IPF animal models and has shown favorable tolerability in...

pdf

Also known as: 69-89-6, 2,6-dihydroxypurine, Xanthin, 2,6-dioxopurine, Isoxanthine, Pseudoxanthine

Molecular Formula

C5H4N4O2

Molecular Weight

152.11086  g/mol

InChI Key

LRFVTYWOQMYALW-UHFFFAOYSA-N

FDA UNII

1AVZ07U9S7

chemical compound

Read More

Also known as: 6754-58-1, 1-(2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)phenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one, 569-83-5, Unii-t4467yt1nt, Chebi:66331, Xanthohumol from hop (humulus lupulus)

Molecular Formula

C21H22O5

Molecular Weight

354.39638  g/mol

InChI Key

ORXQGKIUCDPEAJ-YRNVUSSQSA-N

Read More

PharmaCompass >>